These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 25319651)

  • 1. Targeted in vivo delivery of siRNA and an endosome-releasing agent to hepatocytes.
    Sebestyén MG; Wong SC; Trubetskoy V; Lewis DL; Wooddell CI
    Methods Mol Biol; 2015; 1218():163-86. PubMed ID: 25319651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte-targeted RNAi therapeutics for the treatment of chronic hepatitis B virus infection.
    Wooddell CI; Rozema DB; Hossbach M; John M; Hamilton HL; Chu Q; Hegge JO; Klein JJ; Wakefield DH; Oropeza CE; Deckert J; Roehl I; Jahn-Hofmann K; Hadwiger P; Vornlocher HP; McLachlan A; Lewis DL
    Mol Ther; 2013 May; 21(5):973-85. PubMed ID: 23439496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
    Sun Y; Li Z; Li L; Li J; Liu X; Li W
    Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonviral pulmonary delivery of siRNA.
    Merkel OM; Kissel T
    Acc Chem Res; 2012 Jul; 45(7):961-70. PubMed ID: 21905687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of RNA interference to modulate liver adenoma development in a murine model transgenic for hepatitis B virus.
    Chen CC; Chang CM; Sun CP; Yu CP; Wu PY; Jeng KS; Hu CP; Chen PJ; Wu JC; Shih CH; Gershwin ME; Tao MH
    Gene Ther; 2012 Jan; 19(1):25-33. PubMed ID: 21562593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opportunities for treating chronic hepatitis B and C virus infection using RNA interference.
    Arbuthnot P; Longshaw V; Naidoo T; Weinberg MS
    J Viral Hepat; 2007 Jul; 14(7):447-59. PubMed ID: 17576386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymers for siRNA delivery: inspired by viruses to be targeted, dynamic, and precise.
    Wagner E
    Acc Chem Res; 2012 Jul; 45(7):1005-13. PubMed ID: 22191535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient inhibition of hepatitis B virus replication by small interfering RNAs targeted to the viral X gene in mice.
    Shin D; Kim SI; Kim M; Park M
    Virus Res; 2006 Aug; 119(2):146-53. PubMed ID: 16443303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploiting the RNA interference pathway to counter hepatitis B virus replication.
    Arbuthnot P; Carmona S; Ely A
    Liver Int; 2005 Feb; 25(1):9-15. PubMed ID: 15698393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EsiRNAs inhibit Hepatitis B virus replication in mice model more efficiently than synthesized siRNAs.
    Xuan B; Qian Z; Hong J; Huang W
    Virus Res; 2006 Jun; 118(1-2):150-5. PubMed ID: 16423421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative assessment of the antiviral potencies of 21 shRNA vectors targeting conserved, including structured, hepatitis B virus sites.
    Sun D; Rösler C; Kidd-Ljunggren K; Nassal M
    J Hepatol; 2010 Jun; 52(6):817-26. PubMed ID: 20400195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term inhibition of hepatitis B virus in transgenic mice by double-stranded adeno-associated virus 8-delivered short hairpin RNA.
    Chen CC; Ko TM; Ma HI; Wu HL; Xiao X; Li J; Chang CM; Wu PY; Chen CH; Han JM; Yu CP; Jeng KS; Hu CP; Tao MH
    Gene Ther; 2007 Jan; 14(1):11-9. PubMed ID: 16929350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel pH-sensitive multifunctional envelope-type nanodevice for siRNA-based treatments for chronic HBV infection.
    Yamamoto N; Sato Y; Munakata T; Kakuni M; Tateno C; Sanada T; Hirata Y; Murakami S; Tanaka Y; Chayama K; Hatakeyama H; Hyodo M; Harashima H; Kohara M
    J Hepatol; 2016 Mar; 64(3):547-55. PubMed ID: 26505121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of hepatitis B virus replication by recombinant small interfering RNAs.
    Wu K; Gong Y; Zhang X; Zhang Y; Mu Y; Liu F; Song D; Zhu Y; Wu J
    Acta Virol; 2005; 49(4):235-41. PubMed ID: 16402680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct cytosolic siRNA delivery by reconstituted high density lipoprotein for target-specific therapy of tumor angiogenesis.
    Ding Y; Wang Y; Zhou J; Gu X; Wang W; Liu C; Bao X; Wang C; Li Y; Zhang Q
    Biomaterials; 2014 Aug; 35(25):7214-27. PubMed ID: 24875759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimized RNA interference therapeutics combined with interleukin-2 mRNA for treating hepatitis B virus infection.
    Zai W; Yang M; Jiang K; Guan J; Wang H; Hu K; Huang C; Chen J; Fu W; Zhan C; Yuan Z
    Signal Transduct Target Ther; 2024 Jun; 9(1):150. PubMed ID: 38902241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
    Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
    Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic analysis of anti-hepatitis B virus (HBV) activity by small interfering RNA and lamivudine in stable HBV-producing cells.
    Guo Y; Guo H; Zhang L; Xie H; Zhao X; Wang F; Li Z; Wang Y; Ma S; Tao J; Wang W; Zhou Y; Yang W; Cheng J
    J Virol; 2005 Nov; 79(22):14392-403. PubMed ID: 16254373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication.
    Morrissey DV; Blanchard K; Shaw L; Jensen K; Lockridge JA; Dickinson B; McSwiggen JA; Vargeese C; Bowman K; Shaffer CS; Polisky BA; Zinnen S
    Hepatology; 2005 Jun; 41(6):1349-56. PubMed ID: 15880588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
    Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q
    Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.